Floatz logo

Epoetin Alfa

Stomach Neoplasms

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3Dormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
81/ 100

Competitive context

35 Active assets in the Stomach Neoplasms cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Seagen, a wholly owned subsidiary of Pfizer
Phase 4BBB
Capecitabine
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 3BB
Eloxatin
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Jazz Pharmaceuticals
Phase 3BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3BB

View all 50 →

Same molecule, other indications

Epoetin Alfa is also rated in:

anemiaDormant
BBB
Indicative ·
79 / 100
View asset →
plasma cell myelomaDormant
BB
Indicative ·
71 / 100
View asset →
precancerous conditionDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →